project id: TCGA-OV; case submitter id: TCGA-13-0730; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 7.7; spectrophotometer method: UV Spec; age at index: 71; days to birth: -26086; days to death: 542; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1932; year of death: 2004; age at diagnosis: 26086; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2003; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; portion number: 01; weight: 101.0; composition: Not Reported; intermediate dimension: 0.6; longest dimension: 1.1; preservation method: Unknown; shortest dimension: 0.4; sample id: bbe4ea81-6f31-4589-8797-b140bcb35d2b; sample submitter id: TCGA-13-0730-01A; portion id: 043bee4f-3d2f-41dc-9dcd-bce9eac3bd48; portion submitter id: TCGA-13-0730-01A-01; percent lymphocyte infiltration: 50.0; percent necrosis: 5.0; percent neutrophil infiltration: 50.0; percent normal cells: 0.0; percent tumor nuclei: 95.0;